In December 2021, the U.S. FDA approved injectable cabotegravir (Apretude) as pre-exposure prophylaxis (PrEP) to prevent HIV transmission. PrEP, post-exposure…
		
		
		
		
		
		
		
		
		
		Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
Privacy Policy
